Skip to content

Butamben

Drug profile

Also known as: butambene, butesin, butesine, butoform, butyl 4-aminobenzoate, butylcaine

FDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Butamben is a drug catalogued in DrugCentral. Recorded indications include Itching of skin, Minor Skin Wound Pain and Skin irritation.

  • Indications: Itching of skin, Minor Skin Wound Pain and Skin irritation.
  • Molecular formula: C11H15NO2; molecular weight 193.25 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Itching of skin
  • Minor Skin Wound Pain
  • Skin irritation

Contraindications (5)

  • Conduction disorder of the heart
  • Decreased respiratory function
  • Denuded skin
  • Open wound
  • Seizure disorder

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Butamben is on its molecule page.

Molecular formulaC11H15NO2
Molecular weight193.25 g/mol
CAS number94-25-7
InChIKeyIUWVALYLNVXWKX-UHFFFAOYSA-N
PubChem CID2482
CCCCOC(=O)C1=CC=C(N)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Butamben used for?

DrugCentral lists the following indications for Butamben: Itching of skin, Minor Skin Wound Pain and Skin irritation.

What is the chemical formula of Butamben?

Butamben has the molecular formula C11H15NO2 and a molecular weight of 193.25 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets0
Indications3
FormulaC11H15NO2
DrugCentral ID3051
Interactive profile